Clinical Trials Directory

Trials / Completed

CompletedNCT01157026

A Pilot Clinical Trial With Tocotrienol on Breast Cancer

Effectiveness of Tocotrienol-rich Fraction Combined With Tamoxifen in the Management of Women With Early Breast Cancer: A Pilot Clinical Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
240 (actual)
Sponsor
Malaysia Palm Oil Board · Other Government
Sex
Female
Age
40 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Tocotrienol Rich Fraction (TRF) in combination with Tamoxifen will improve breast cancer specific survival and recurrence free survival, in women with early breast cancer and estrogen receptor positive tumors.

Detailed description

We conducted a, double-blinded, placebo controlled trial of TRF plus tamoxifen versus placebo plus tamoxifen in women with primary breast cancer for five years. Both the TRF and placebo drugs were prepared and supplied by Hovid Sdn Bhd, Malaysia. Hovid Sdn. Bhd. absolutely did not have any influence in the trial designing, patient recruitment, data collection, analysis and reporting. The placebo drug which contained soy oil without tocotrienols had similar appearance and taste as the TRF drug. A total of 240 women breast cancer patients were assigned to two groups by minimization method that balanced treatment groups. The intervention group was given TRF plus tamoxifen, (n = 120) while control group was given placebo plus tamoxifen, (n = 120). The primary end point was breast cancer specific survival, defined as the time from minimization to death due to breast cancer. The secondary end points included disease free survival, biochemical parameters, liver function and plasma levels of vitamin E.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTTocotrienol Rich Fraction (TRF)Tocotrienol Rich Fraction (200mg), daily for five years
OTHERplacebo plus tamoxifen20mg tamoxifen daily

Timeline

Start date
2001-11-01
Primary completion
2006-11-01
Completion
2010-01-01
First posted
2010-07-05
Last updated
2010-07-05

Locations

1 site across 1 country: Malaysia

Source: ClinicalTrials.gov record NCT01157026. Inclusion in this directory is not an endorsement.